Yahoo Finance [Yahoo! Finance]
Sutro Biopharma, Inc. (STRO)
Last sutro biopharma, inc. earnings: 11/8 07:00 am
Check Earnings Report
Company Research
Source: Yahoo! Finance
The company recently moved its headquarters from Sunnyvale to South San Francisco. 23andMe “has publicly reported that it is in financial distress and stated in securities filings that there is substantial doubt about its ability to continue, which is a growing concern. Due to the trove of sensitive consumer data 23andMe has amassed, Attorney General Bonta reminds Californians of their right to direct the deletion of their genetic data,” the AG's office wrote. The Genetic Information Privacy Act (GIPA) and California Consumer Protection Act (CCPA) protect Californians. Customers who want to invoke these rights can do so by going to 23andMe's website. Bonta said, “Given 23andMe's reported financial distress, I remind Californians to consider invoking their rights and directing 23andMe to delete their data and destroy any samples of genetic material held by the company.” Turmoil for 23andMe included a high-profile data breach, several rounds of previous layoffs and piling losse
Show less
Read more
Impact Snapshot
Event Time:
STRO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
STRO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
STRO alerts
High impacting Sutro Biopharma, Inc. news events
Weekly update
A roundup of the hottest topics
STRO
News
- Sutro Biopharma Announces 1-for-10 Reverse Stock Split [Yahoo! Finance]Yahoo! Finance
- Sutro Biopharma Announces 1-for-10 Reverse Stock SplitGlobeNewswire
- Sutro Biopharma (NASDAQ:STRO) had its "sell (e+)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Sutro Biopharma Highlights Next-Generation ADC Innovation at Virtual R&D Day [Yahoo! Finance]Yahoo! Finance
- Sutro Biopharma Highlights Next-Generation ADC Innovation at Virtual R&D DayGlobeNewswire
STRO
Earnings
- 5/8/25 - Miss
STRO
Sec Filings
- 12/3/25 - Form 8-K
- 11/6/25 - Form 10-Q
- 11/6/25 - Form 8-K
- STRO's page on the SEC website